MedPath

Ambicef-S

Brand Name: Ambicef-S

Generic Name: Ceftriaxone (as sodium) + Sulbactam (as sodium)

Active
Registration Number

DRP-11592

Dosage Form

Powder for Injection (I.M./I.V.)

Issuance Date

March 31, 2022

Expiry Date

March 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1.5 g
Packaging20 mL-capacity USP Type I clear and colorless glass vial with grey bromobutyl rubber stopper and aluminum seal with lime green colored flip-off cap in individual box (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin-Beta-Lactamase Inhibitor Combination)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Ceftriaxone (as sodium)Active
Sulbactam (as sodium)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform